Dr. Bose on the Management of Patients With Myelofibrosis Who Progress on Ruxolitinib
June 8th 2020
Prithviraj Bose, MD, associate professor in the Department of Leukemia of the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center, discusses management strategies for patients with myelofibrosis who progress on ruxolitinib (Jakafi).